Skip to main content
. 2007 Dec;18(5):306–320.

TABLE 1.

Summary of Previous ABRF Edman Sequencing Studies

Sample Description Study Purpose Amount (pmol) Positive Accuracy Tentative Accuracy No. of Participants
STD-1 Peptide Sequence analysis 100 95% 48% 54
ABRF-89SEQ 2 peptides Differentiation of 2 sequences 240/48 95% 57% 48
ABRF-90SEQ Peptide conjugated to acetylated protein (PVDF) Evaluate PVDF-bound sample 30 82% 43% 55
ABRF-91SEQ Peptide conjugated to acetylated protein Compare solution sample to PVDF 50 83% 55% 90
ABRF-92SEQ Peptide Determine 2 posttranslational modifications (PSer & HyPro) 500 94% 64% 74
ABRF-93SEQ Rearrangement of STD1 Determine improvement 50 91% 56% 80
ABRF 94SEQ Protein Cys & Trp determination 50 96% 55% 78
ABRF-95SEQ Protein 4 Cycles of microheterogeniety, length of sequence read 45 78% 45% 71
ABRF-96SEQA Dataset Single sequence calling ability 40 100% 86% 95
ABRF-96SEQB major Dataset Sequence calling ability in a mixture 10 96% 58% 95
ABRF-96SEQB minor Dataset Sequence calling ability in a mixture 2 86% 38% 95
ABRF-97SEQ major Peptide, rear-rangement of 96SEQB major Compare lab-generated data to previous year’s dataset 10 92% 54% 50
ABRF-97SEQ minor Peptide, rear-rangement of 96SEQB minor Compare lab-generated data to previous year’s dataset 2 72% 38% 50
ABRF-98SEQ Peptide Read low-level sequence & use MS/MS data if possible 2.8 91% 45% 56
ABRF-99SEQ protein Protein/peptide mix Distinguish 2 sequences, protein ID using BLAST search 10 99% 58% 45
ABRF-99SEQ peptide Protein/peptide mix Distinguish 2 sequences 5 95% 62% 45
ABRF-00SEQ Rearrangement of ABRF-92SEQ Determine 2 post translational modifications 5 86% 47% 46
ESRG-2002 Protein Heterogeneous N-terminus, protein ID using BLAST 35 76% 73% 31
ESRG-2003 Protein Homogeneous N-terminus, protein ID 13.5 97% 77% 46
ESRG-2004 Peptide Identify 7 post translational modifications 775 96% 57% 20
ESRG-2005 Peptide Identify 7 additional post translational modifications 2000 80% 42% 27
ESRG-2006 3 Peptide Mix Sequence & quantify peptides identify modified amino acid 40/40 (2 homologs) 88% 67% 18
20 (third peptide) 93% 44%